Study guide

11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation

Key Takeaways Explain This Topic AI

Positive pressure ventilation must begin within 60 seconds of birth when the infant is apneic, gasping, or has a heart rate below 100 bpm.

PPV is delivered at 40 to 60 breaths per minute with an initial peak inspiratory pressure of 20 to 25 cm H2O and PEEP of 5 cm H2O.

Resuscitation of infants at 35 weeks or later begins with 21 percent oxygen, and preterm infants below 35 weeks with 21 to 30 percent.

The pulse oximeter probe goes on the right hand or wrist because pre-ductal blood reflects what is perfusing the brain and heart.

Target pre-ductal saturation is only 60 to 65 percent at 1 minute, rising to 85 to 95 percent by 10 minutes.

Last updated: September 2026

The "Golden Minute" & Positive Pressure Ventilation (PPV)

At 30 seconds of life , assess respirations and heart rate. Evaluate the heart rate by auscultating the precordium with a stethoscope for 6 seconds and multiplying by 10 (or using a 3-lead ECG monitor).

[!CRITICAL] The Golden Minute Rule: If the neonate is apneic, gasping, OR has a heart rate <100 bpm after the initial steps, the clinician MUST initiate Positive Pressure Ventilation (PPV) within 60 seconds of birth ("the Golden Minute"). Effective ventilation is the single most critical and effective intervention in neonatal resuscitation.

Technical Standards for Positive Pressure Ventilation

Ventilation Rate: 40 to 60 breaths per minute . Use the rhythmic verbal cadence: "Breathe, two, three, breathe, two, three..." (squeeze on "Breathe", release on "two, three").

Inspiratory Pressures: Initial Peak Inspiratory Pressure ( PIP ) of 20 to 25 cm H2O ; Positive End-Expiratory Pressure ( PEEP ) of 5 cm H2O (delivered via a T-piece resuscitator or flow-inflating bag; self-inflating bags require an attached PEEP valve).

Initial Oxygen Concentration (FiO2):

Term and late-preterm infants (≥35 weeks): Begin resuscitation with 21% oxygen (room air) . Initiating resuscitation with 100% oxygen in term neonates increases mortality, prolongs time to spontaneous respiration, and generates toxic reactive oxygen species causing reperfusion injury to the brain and myocardium.

Preterm infants (<35 weeks): Begin resuscitation with 21% to 30% oxygen .

Pulse Oximetry Monitoring: Place a pulse oximeter sensor on the right hand or right wrist (pre-ductal site) before connecting the cable to the monitor. Pre-ductal blood reflects the exact oxygen concentration perfusing the cerebral circulation and heart via the carotid and coronary arteries (upstream of the ductus arteriosus).

Target Pre-Ductal SpO2 Milestones

Healthy neonates do not achieve adult oxygen saturation levels immediately. The NRP target pre-ductal SpO2 milestones are: Time from Birth Target Pre-Ductal S p O 2 1 minute 60 % − 65 % 2 minutes 65 % − 70 % 3 minutes 70 % − 75 % 4 minutes 75 % − 80 % 5 minutes 80 % − 85 % 10 minutes 85 % − 95 % \begin{array}{|c|c|} \hline \textbf{Time from Birth} & \textbf{Target Pre-Ductal } \mathbf{SpO_2} \\ \hline 1 \text{ minute} & 60\% - 65\% \\ \hline 2 \text{ minutes} & 65\% - 70\% \\ \hline 3 \text{ minutes} & 70\% - 75\% \\ \hline 4 \text{ minutes} & 75\% - 80\% \\ \hline 5 \text{ minutes} & 80\% - 85\% \\ \hline 10 \text{ minutes} & 85\% - 95\% \\ \hline \end{array} Time from Birth 1 minute 2 minutes 3 minutes 4 minutes 5 minutes 10 minutes ​ Target Pre-Ductal Sp O 2 ​ 60% − 65% 65% − 70% 70% − 75% 75% − 80% 80% − 85% 85% − 95% ​ ​

Titrate the blender oxygen concentration (FiO2) up or down to keep the infant's pre-ductal SpO2 within these physiological windows, avoiding both hypoxemia and hyperoxia.

Ventilation Corrective Steps: The MR. SOPA Mnemonic

Assess heart rate and chest movement 15 seconds after initiating PPV:

If the heart rate is increasing: Continue PPV. Reassess heart rate at 30 seconds.

If the heart rate is NOT increasing but the chest IS moving: Continue PPV for another 15 seconds (total 30 seconds) and reassess.

If the heart rate is NOT increasing and the chest is NOT moving: Effective ventilation has NOT been established. Immediately interrupt ventilation to perform the MR. SOPA corrective steps in pairs: MR. SOPA Ventilation Corrective Ladder

  • ├── 1. M & R ──> Mask Adjustment (reseal) + Reposition Head (sniffing) ──> Test 5 breaths
  • ├── 2. S & O ──> Suction Mouth/Nose + Open Mouth (jaw thrust) ──> Test 5 breaths
  • ├── 3. P ──> Pressure Increase (+5 cm H2O increments to max 40) ──> Test 5 breaths
  • └── 4. A ──> Alternative Airway (Endotracheal Tube or Laryngeal Mask)

M & R (Mask and Reposition):

M - Mask Adjustment: Re-apply the mask with gentle downward pressure to establish an airtight seal against the infant's face. Use the "C-and-E" hand grip.

R - Reposition Head: Re-position the head and neck into the neutral "sniffing" position.

Check: Deliver 5 breaths; observe for chest rise.

S & O (Suction and Open):

S - Suction Mouth and Nose: Clear the pharynx and nares of thick secretions or mucus using a bulb syringe or suction catheter.

O - Open Mouth: Lift the jaw forward and open the infant's mouth slightly.

Check: Deliver 5 breaths; observe for chest rise.

P (Pressure Increase):

P - Pressure Increase: Incrementally increase the peak inspiratory pressure by 5 cm H2O increments , assessing chest rise after each change, up to a maximum PIP of 30 to 40 cm H2O for term infants.

Check: Deliver 5 breaths; observe for chest rise.

A (Alternative Airway):

A - Alternative Airway: Insert an endotracheal tube (ETT) or a laryngeal mask airway (LMA) . Secure the airway, verify bilateral breath sounds, confirm exhaled CO2 with a colorimetric detector, and deliver 30 seconds of effective PPV that moves the chest.

  • Advanced Resuscitation: Chest Compressions & Emergency Pharmacotherapy
  • Indication for Chest Compressions

Chest compressions are indicated ONLY when the heart rate remains <60 beats per minute despite at least 30 seconds of effective PPV that moves the chest (almost always following placement of an endotracheal tube or laryngeal mask).

Compressions Technique & Parameters

FiO2 Escalation: Increase the delivered oxygen concentration to 100% FiO2 whenever chest compressions are initiated.

Technique: The 2-thumb encircling-hands technique is strongly preferred over the 2-finger technique because it generates superior peak systolic pressures, higher coronary perfusion gradients, and causes less rescuer fatigue. Place both thumbs side-by-side or overlapping on the lower third of the sternum , directly between the nipples, avoiding the xiphoid process. Encircle the infant's torso with fingers supporting the spine.

Compression Depth & Recoil: Depress the sternum approximately one-third of the anterior-posterior (AP) diameter of the chest (approximately 1.5 inches in a term infant). Ensure complete chest wall recoil between compressions without allowing the thumbs to lose contact with the sternum.

Ratio and Cadence: Deliver compressions and ventilations in a 3:1 ratio (3 compressions to 1 ventilation). Coordinate 90 compressions and 30 ventilations per minute , totaling 120 events per minute . Use the rhythmic cadence: "One-and-two-and-three-and-breathe-and..."

Continuous Resuscitation: Continue coordinated compressions and ventilations for at least 60 seconds before pausing briefly to reassess the heart rate. A 3-lead ECG monitor should be utilized to minimize interruptions in chest compressions.

Emergency Pharmacotherapy: Epinephrine & Volume Expansion

If the neonatal heart rate remains <60 bpm despite at least 60 seconds of chest compressions coordinated with effective 100% PPV via an alternative airway , emergency pharmacotherapy is urgently indicated.

Medication / Fluid Concentration & Preparation Route & Dosage Administration Protocol & Clinical Rationale

Epinephrine (Adrenaline) 0.1 mg/mL (formerly labeled 1:10,000 solution) Intravenous (IV) or Intraosseous (IO): 0.02 mg/kg (= 0.2 mL/kg of 0.1 mg/mL formulation) Preferred route. Administer as a rapid IV push via an emergency umbilical venous catheter (UVC) inserted 2–4 cm into the umbilical vein. Follow immediately with a 3 mL normal saline flush to propel the drug into the central venous circulation. Repeat every 3 to 5 minutes if HR <60 bpm.

Epinephrine (Endotracheal) 0.1 mg/mL (1:10,000) Endotracheal (ETT): 0.1 mg/kg (= 1.0 mL/kg of 0.1 mg/mL formulation) Temporary measure only while vascular access is being established. Dilute or follow with positive-pressure breaths to disperse into the distal tracheobronchial tree. Note: ETT dosing is 5 times higher due to erratic alveolar absorption.

Volume Expander 0.9% Normal Saline (0.9% NaCl) or uncrossmatched Type O Rh-negative PRBCs IV or IO: 10 mL/kg Indicated for documented or suspected acute hypovolemia/blood loss (e.g., placental abruption, vasa previa, fetomaternal hemorrhage, cord avulsion) AND poor response to resuscitation (pale, weak pulses, persistent bradycardia). Infuse steadily over 5 to 10 minutes . Avoid rapid boluses in preterm infants to prevent intraventricular hemorrhage.

Caution

Medications No Longer Recommended: Sodium bicarbonate, atropine, and calcium gluconate are NOT recommended during acute neonatal resuscitation. Sodium bicarbonate produces hypercarbia and worsens intracellular acidosis; atropine is ineffective against hypoxemic bradycardia; and routine calcium administration is associated with myocardial injury.

Loading diagram... Neonatal Resuscitation Program (NRP 8th Edition) Algorithmic Flowchart